Dyskeratosis Congenita and Cancer in Mice Deficient in Ribosomal RNA Modification

Davide Ruggero(Memorial Sloan Kettering Cancer Center), Silvia Grisendi(Memorial Sloan Kettering Cancer Center), Francesco Piazza(Memorial Sloan Kettering Cancer Center), Eduardo Magalhães Rego(Memorial Sloan Kettering Cancer Center), Francesca Mari(Memorial Sloan Kettering Cancer Center), Pulivarthi H. Rao(Baylor College of Medicine), Carlos Cordon‐Cardo(Memorial Sloan Kettering Cancer Center), Pier Paolo Pandolfi(Memorial Sloan Kettering Cancer Center)
Science
January 9, 2003
Cited by 429

Abstract

Mutations in DKC1 cause dyskeratosis congenita (DC), a disease characterized by premature aging and increased tumor susceptibility. The DKC1 protein binds to the box H + ACA small nucleolar RNAs and the RNA component of telomerase. Here we show that hypomorphic Dkc1 mutant (Dkc1m) mice recapitulate in the first and second generations (G1 and G2) the clinical features of DC. Dkc1m cells from G1 and G2 mice were impaired in ribosomal RNA pseudouridylation before the onset of disease. Reductions of telomere length in Dkc1m mice became evident only in later generations. These results suggest that deregulated ribosome function is important in the initiation of DC, whereas telomere shortening may modify and/or exacerbate DC.


Related Papers

No related papers found

Powered by citation graph analysis